Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.
Daniel Carrizosa, MD, MS
Advertisement
Daniel Carrizosa, MD, MS, is a physician at Atrium Health Levine Cancer Institute and associate professor of cancer medicine at Wake Forest University School of Medicine in Charlotte, North Carolina.
Articles by Daniel Carrizosa, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Tentative Approval to Generic Olaparib Tablets
2
GU Oncology Trial Logistics: Nursing Insights from Dana-Farber
3
Study Reports 10-Year Outcomes of Focal Therapy for Prostate Cancer
4
Optimizing Multiple Myeloma Care: Insights From a Nursing Expert
5